Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (7836)	11/25/1998 12:18:00 PM
From: aknahow	Respond to of 17367

I anticipated that the short interest would decline. See some or one on Yahoo still thinks shorting by the c.v.p. owners, will be a future event, having not figured out or not wanting to understand that conversion is done to cover the existing shorts. 2,086,050 this period compared to 2,251,581 A decline of 7%.

To: Bluegreen who wrote (7836)	11/25/1998 1:02:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Did you anticipate the return of the surficant issue? From the gram positive patent: In addition, the invention provides a method of killing or inhibiting growth of gram-positive bacteria comprising contacting the bacteria with a BPI protein product alone, or in combination with another antibacterial agent. This method can be practiced in vivo or in a variety of in vitro uses such as use in food preparation, to decontaminate fluids and surfaces or to sterilize surgical and other medical equipment and implantable devices, including prosthetic joints. These methods can correspondingly be used for in situ sterilization of indwelling invasive devices such as intravenous lines and catheters, which are often foci of infection, or for sterilization of in vitro tissue colture media.